Product Liability in Europe and the UK with Emerging Technologies

Exploration of product liability adaptation in the UK and Europe with the rise of emerging technologies like Artificial Intelligence.

As new technologies, including Artificial Intelligence, permeate various industries, product liability laws in Europe and the UK are facing scrutiny and adaptation. Historically, the UK has contrasted sharply with the United States in its handling of group actions, particularly highlighted by unsuccessful legal pursuits in cases involving tobacco products. This marks a broader trend where regional legal frameworks struggle to keep pace with rapid technological advancements.

The adaptation process in the UK involves tackling novel challenges that these emerging technologies present, from integrating them into the current legal schema to addressing the unique liability issues they provoke. The usage of Artificial Intelligence introduces complex scenarios where traditional causality is harder to establish, thus complicating liability determinations and pushing for legal evolution.

In Europe, a similar reevaluation is underway. As nations within the European Union navigate the integration of advanced technologies in commerce and personal life, there´s a concerted effort to ensure that the existing legal systems remain robust yet adaptable. The European Commission has been proactive in exploring regulatory changes that adequately address the implications of technologies, ensuring both innovation and consumer protection are maintained.

65

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.